AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay(TM) blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced ...
At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...
McDonald's is exploring ways to cater to the growing number of Americans taking GLP-1 weight-loss drugs, such as Ozempic and Wegovy, by testing high-protein menu items. CEO Chris Kempczinski revealed ...
Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results